THE EFFECT OF ANTIOXIDANT THERAPY ON THE CHANGES OF CLINICAL AND LABORATORY PARAMETERS IN ALCOHOL DRINKERS WITH PULMONARY TUBERCULOSIS

  • Ivan Hrek Department of General Practice-Family Medicine, Phthisiology and Pulmonology, Kharkiv Mediсal Aсademy of Postgraduate Eduсation, Kharkiv, Ukraine; Department of Infectious Diseases and Clinical Immunology, V. N. Karazin Kharkiv National University, Kharkiv, Ukraine https://orcid.org/0000-0002-2305-8630
  • Maryna Kochuieva Department of Internal Medicine, V. N. Karazin Kharkiv National University, Kharkiv, Ukraine https://orcid.org/0000-0002-1516-2155
  • Valentyna Psarova Department of Internal Medicine with the Center of Respiratory Medicine, Sumy State University, Sumy, Ukraine https://orcid.org/0000-0001-6890-272X
  • Hennady Kochuiev Department of General Practice-Family Medicine, Phthisiology and Pulmonology, Kharkiv Mediсal Aсademy of Postgraduate Eduсation, Kharkiv, Ukraine https://orcid.org/0000-0003-1039-7489
  • Anton Rohozhyn Department of General Practice-Family Medicine, Phthisiology and Pulmonology, Kharkiv Mediсal Aсademy of Postgraduate Eduсation, Kharkiv, Ukraine; Department of Infectious Diseases and Clinical Immunology, V. N. Karazin Kharkiv National University, Kharkiv, Ukraine https://orcid.org/0000-0002-9553-814X
Keywords: tuberculosis, alcohol consumption, antioxidants, immunity, oxidative stress

Abstract

Objective. Determination of the effect of antioxidants on clinical and laboratory parameters in alcohol drinkers with infiltrative newly-diagnosed pulmonary tuberculosis (PTB).

Materials and Methods. 109 patients with newly-diagnosed PTB were examined. All patients underwent a comprehensive medical examination, immunological blood tests, determination of the parameters of the oxidative stress-antioxidant defense system. Patients were divided into three main groups, depending on the level of alcohol consumption. Patients in each of the three groups were further divided into two subgroups depending on the treatment regimen. Statistical analysis was performed using the STATISTICA program.

Results. In patients who received standard therapy, increased alcohol consumption was associated with a decrease in the positive changes of the majority of inflammation and immune status indicators. This trend, in particular, was observed with regard to the progress of the decay cavities closure, persistence of cough complaints, changes in indicators of the immune-inflammatory (CRP, CD8+, CD4/CD8, PAMW, IPC) and oxidative status (SOD, GPX) (p ≤ 0.05). After the antioxidants had been added, the best improvement of immune-inflammatory and oxidative status was observed in group 2 (p ≤ 0.05). Additional antioxidant therapy in patients with newly-diagnosed PTB, regardless of alcohol consumption, contributed to better positive dynamics of cellular immunity, oxidative stress, and endogenous intoxication.

Conclusions. The addition of antioxidant drugs to the standard therapy of patients with newly-diagnosed PTB was accompanied by improved clinical and radiological, oxidative and immune-inflammatory parameters. Antioxidant therapy in such patients, regardless of the initial level of alcohol consumption, promoted better positive dynamics of phagocytic and enzymatic activity of neutrophils, oxidative stress, and endogenous intoxication. The best changes in immune-inflammatory and oxidative status among patients taking antioxidants were observed in those who took alcohol at a health-threatening level.

Author Biographies

Ivan Hrek, Department of General Practice-Family Medicine, Phthisiology and Pulmonology, Kharkiv Mediсal Aсademy of Postgraduate Eduсation, Kharkiv, Ukraine; Department of Infectious Diseases and Clinical Immunology, V. N. Karazin Kharkiv National University, Kharkiv, Ukraine

Ph.D, Assistant Professor of the Department of Infectious Diseases and Clinical Immunology of V.N. Karazin Kharkiv National University, assistant of the department of general practice-family medicine, phthisiology and pulmonology of the Kharkiv Medical Academy of Postgraduate Education; 58, Amosova, st., 61176, Kharkiv; phone: 0660654370, e-mail: grek.ivan.md@gmail.com

Maryna Kochuieva, Department of Internal Medicine, V. N. Karazin Kharkiv National University, Kharkiv, Ukraine

Doctor of Medicine, professor of the Department of Internal Medicine of V.N. Karazin Kharkiv National University, (057) 738-71-87, e-mail: kochuevamarina@gmail.com

Valentyna Psarova, Department of Internal Medicine with the Center of Respiratory Medicine, Sumy State University, Sumy, Ukraine

Doctor of Medicine, professor of the Department of Internal Medicine with the Center of Respiratory Medicine of Sumy State University; 2, Rymskoho-Korsakova str., 40007, Sumy; phone: 0958121386, e-mail: valentinapsareva27@gmail.com

Hennady Kochuiev, Department of General Practice-Family Medicine, Phthisiology and Pulmonology, Kharkiv Mediсal Aсademy of Postgraduate Eduсation, Kharkiv, Ukraine

PhD, Associate Professor of the Department of General Practice-Family Medicine, Phthisiology and Pulmonology, Kharkiv Medical Academy of Postgraduate Education; 58, Amosova, st., 61176, Kharkiv; phone: 05030306111, e-mail: docentik1961@gmail.com

Anton Rohozhyn, Department of General Practice-Family Medicine, Phthisiology and Pulmonology, Kharkiv Mediсal Aсademy of Postgraduate Eduсation, Kharkiv, Ukraine; Department of Infectious Diseases and Clinical Immunology, V. N. Karazin Kharkiv National University, Kharkiv, Ukraine

PhD, Associate Professor of the Department of Infectious Diseases and Clinical Immunology of V.N. Karazin Kharkiv National University; Associate Professor of the Department of General Practice-Family Medicine, Phthisiology and Pulmonology of Kharkiv Medical Academy of Postgraduate Education; 197, Moskovsky ave., 61037, Kharkiv; phone: 738-71-87, e-mail: pekin2006@ukr.net

References

1. Achkar JM, Chan J & Casadevall A. (2017). B cells and antibodies in the defense against Mycobacterium tuberculosis infection. Immunological reviews, 264(1), 167–181. https://doi.org/10.1111/imr.12276
2. Butov D, Zaitseva S, Butova T. Efficacy and safety of quercetin and polyvinylpyrrolidone in treatment of patients with newly diagnosed destructive pulmonary tuberculosis in comparison with standard antimycobacterial therapy. Int J Mycobacteriol. 2016 Dec;5 Suppl 1:S110-S111. doi: 10.1016/j.ijmyco.2016.09.046. Epub 2016 Nov 16. PMID: 28043493.
3. Shastri MD, Shukla SD, Chong WC, Dua K, Peterson GM, Patel RP, Hansbro PM, Eri R & O'Toole RF. (2018). Role of Oxidative Stress in the Pathology and Management of Human Tuberculosis. Oxidative medicine and cellular longevity, 2018, 7695364. https://doi.org/10.1155/2018/7695364
4. Zhai W, Wu F, Zhang Y, Fu Y, Liu Z. The Immune Escape Mechanisms of Mycobacterium Tuberculosis. Int J Mol Sci. 2019 Jan 15;20(2):340. doi: 10.3390/ijms20020340. PMID: 30650615; PMCID: PMC6359177.
5. Mishra BB, Lovewell RR, Olive AJ, Zhang G, Wang W, Eugenin E, Smith CM, Phuah JY, Long JE, Dubuke ML, Palace SG, Goguen JD, Baker RE, Nambi S, Mishra R, Booty MG, Baer CE, Shaffer SA, Dartois V, McCormick BA, Chen X, Sassetti CM. Nitric oxide prevents a pathogen-permissive granulocytic inflammation during tuberculosis. Nat Microbiol. 2017 May 15;2:17072. doi: 10.1038/nmicrobiol.2017.72. PMID: 28504669; PMCID: PMC5461879.
6. Nambi S, Long JE, Mishra BB, Baker R, Murphy KC, Olive AJ, Nguyen HP, Shaffer SA & Sassetti CM. (2015). The Oxidative Stress Network of Mycobacterium tuberculosis Reveals Coordination between Radical Detoxification Systems. Cell host & microbe, 17(6), 829–837. https://doi.org/10.1016/j.chom.2015.05.008
7. Sarangarajan R, Meera S, Rukkumani R, Sankar P & Anuradha G. (2017). Antioxidants: Friend or foe?. Asian Pacific journal of tropical medicine, 10(12), 1111–1116. https://doi.org/10.1016/j.apjtm.2017.10.017
Published
2022-09-30
How to Cite
Ivan Hrek, Maryna Kochuieva, Valentyna Psarova, Hennady Kochuiev, & Anton Rohozhyn. (2022). THE EFFECT OF ANTIOXIDANT THERAPY ON THE CHANGES OF CLINICAL AND LABORATORY PARAMETERS IN ALCOHOL DRINKERS WITH PULMONARY TUBERCULOSIS . Eastern Ukrainian Medical Journal, 10(3), 259-267. https://doi.org/10.21272/eumj.2022;10(3):259-267

Most read articles by the same author(s)